CONMED Corporation (CNMD)
NYSE
Delayed Data
Oct 19, 2026, 01:30 PM
Day's Range
45.8952 wk Range
31.44Overview - CNMD - CONMED Corporation
Key Statistics
Valuation
Enterprise Value
2.12B
P/E (Trailing)
24.01
P/E (Forward)
9.28
PEG Ratio
2.07
Price / Sales (TTM)
0.96
Price / Book
1.27
EV / EBITDA
9.35
Profitability
Gross Margin
57.48%
Profit Margin
4.11%
Operating Margin
14.64%
Return on Assets
4.14%
Return on Equity
5.52%
Ownership
Shares Outstanding
30.14M
Float
29.65M
Short % of Shares Outstanding
7.76%
Held by Insiders
0.43%
Held by Institutions
116.68%
Price stats
Beta
0.94
50-Day Avg
48.01
200-Day Avg
41.04
Dividends
Payout Ratio
10.81%
Frequency
Quarterly
Analyst Consensus
7 analysts
Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - CNMD - CONMED Corporation
Peers - CNMD - CONMED Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NYSE.
Profile Summary - CNMD - CONMED Corporation
About
CONMED Corporation is a medical technology company that develops, manufactures, and sells surgical devices and equipment used in hospitals, ambulatory surgery centers, and other clinical settings. The company’s portfolio supports minimally invasive procedures across orthopedic surgery, general surgery, gynecology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
